DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N, Beghin D, Cuppers-Maarschalkerweerd B, Richardson J et al. on behalf of the network of French pharmacovigilance centers.
Increased risk of birth defects after TNF-α inhibitor therapy during pregnancy? A prospective multicenter cohort study.
Birth Defects Research A 2014;
100: 523
We do not assume any responsibility for the contents of the web pages of other providers.